DeSimone Jill 4
4 · Oncternal Therapeutics, Inc. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
DeSimone Jill
Director
Transactions
- Award
Stock Options
2024-06-20+2,200→ 2,200 totalExercise: $8.10Exp: 2034-06-20→ Common Stock (2,200 underlying)
Footnotes (1)
- [F1]One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.